Ovarian cancer surgery has one goal: to leave no visible cancer behind. That result — written as R0 or CC-0 on the operation note — matters more to what follows than the size of the operation. So the real decision is not whether to operate, but when: now, if everything can be removed, or after three or four cycles of chemotherapy, if it cannot. Heated chemotherapy inside the abdomen (HIPEC) is added only in a specific setting.
Send the CT images, CA-125 and any biopsy or operation notes ahead of your appointment, so the consultation starts with them already read · +91-63590-11009
Dr Swati Shah
MS, DrNB (Surgical Oncology)
HIPEC & Ovary Cancer Surgeon · Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad
Indian Ovary Cancer Institute (IOCI), Shah’s Gastro, Cancer & Robotic Surgery Centre — an institute that works on one organ, the ovary. Trained at high-volume cancer centres, fully qualified in surgical oncology, and 18 years of experience in cancer surgery for women. Rated 5.0 from 18 Google reviews at the IOCI clinic and 4.95 from 56 at Apollo, Bhat.
R0 means no visible residual disease at the end of the operation. CC-0, the completeness-of-cytoreduction score used in peritoneal surgery, means no visible nodule left anywhere. Both describe the same target, and it is the target of every ovarian cancer operation done at the Indian Ovary Cancer Institute.
For many years “optimal debulking” meant leaving nothing larger than a centimetre. That standard has been replaced. The difference between leaving nothing visible and leaving even small nodules is large and consistent across the evidence, so “optimal” is no longer the aim. The aim is always none.
The reason lies in how this cancer behaves. Ovarian, tubal and peritoneal cancer spreads across the surface of the abdomen — the omentum, the undersurface of the diaphragm, the coverings of the bowel — and it usually responds well to platinum chemotherapy. Surgery’s job is to remove everything that can be seen, so that the chemotherapy only has to deal with what cannot be seen.
Resectability is judged from a contrast CT of the chest, abdomen and pelvis, and, where the CT leaves doubt, a diagnostic laparoscopy scored with the Fagotti index. It is never decided on imaging alone when a laparoscopy would settle it.
On the CT, five findings decide most cases:
Blood markers matter too. If the balance between CA-125 and CEA does not point to the ovary, a colonoscopy and upper GI endoscopy are done first, so that a bowel cancer is not operated on as an ovarian one. Tissue is confirmed before any chemotherapy, by an image-guided core biopsy or at laparoscopy.
Primary surgery is chosen when complete removal is achievable and the patient is fit. Chemotherapy first, followed by interval surgery, is chosen when the disease cannot yet be removed completely, or when fitness, nutrition or other illness would make a long operation unsafe. Both are standard; the tumour board makes the choice.
| Primary cytoreduction (surgery first) | Chemotherapy first, then interval cytoreduction | |
|---|---|---|
| Chosen when | Complete removal looks achievable and you are fit | Disease at the mesentery root, porta hepatis or in large volume in the upper abdomen; or poor fitness, low albumin, or other illness |
| Sequence | Operation, then six cycles of chemotherapy | Three or four cycles, the operation, then the remaining cycles to complete six |
| HIPEC | Not established at a first operation — investigational only | Supported by trial evidence when the interval operation is complete |
| Goal | No visible disease | No visible disease |
A complete operation after chemotherapy is better than an incomplete operation at the start. Matching the timing to the disease, so that the result is complete, is the whole of the decision.
An intentionally incomplete operation is never done. If, once the abdomen is open, complete removal proves impossible, tissue is taken, the abdomen is closed, and chemotherapy is given first, with a planned operation to follow.
Families sometimes hear this as “they opened and closed”. It is the opposite of giving up. A long, high-risk operation that leaves disease behind exposes a woman to all of the complications and almost none of the benefit. Stopping, treating, and returning for a complete operation protects both her safety and her chance of a good result. This possibility is explained at the consent discussion, so it is never a surprise.
The operation is tailored to where the disease is. Its fixed core is removal of the uterus, both tubes and ovaries and the omentum; everything else is done only when it is needed to leave nothing visible.
Drains are placed after bowel resection, diaphragm surgery or HIPEC, and not routinely otherwise. A nasogastric tube is not kept routinely.
HIPEC — cisplatin, heated and circulated through the abdomen for ninety minutes at the end of surgery — has trial evidence of a real survival gain at interval cytoreduction after chemotherapy in advanced disease. At a primary operation it is still investigational. It is never added when cytoreduction is incomplete.
Three conditions decide whether HIPEC is offered:
At a first, primary operation, HIPEC is not yet established; the trial addressing that question had not reported when this pathway was last reviewed. If it is discussed in that setting, it is presented to you as investigational.
The heated-perfusion machine is available at Apollo Hospital, Bhat, and is booked, with its team on standby, at the time the operation is listed — so HIPEC is offered here whenever the evidence supports it, rather than when equipment happens to be free.
Whether an operation ends complete depends less on intent than on whether the team can deal with disease on the diaphragm, around the liver and on the bowel in the same sitting. That capability comes from doing this one operation repeatedly, as a team, which is why surgery for advanced ovarian cancer belongs in units that concentrate it.
An operation that stops short because no one present can safely resect the diaphragm or a segment of bowel has failed at its central purpose. At the Indian Ovary Cancer Institute, the ovary is the whole of the work. A GI surgeon joins the operation whenever the bowel or the upper abdomen is involved, so completeness never depends on one person’s range. Anaesthesia and intensive care are planned for a long operation with large fluid shifts, and for the particular kidney care that cisplatin HIPEC needs.
Volume here is not a number to advertise. It is the reason the tumour board can say “complete removal is achievable” with confidence — and the reason it can say “not yet, chemotherapy first” without that meaning surrender.
Preparation starts at the OPD visit, not the night before:
Complications of cytoreductive surgery are named here in words; your own figures, which depend on your age, fitness, albumin and the extent of the operation, are given at the consent discussion.
They include bleeding needing transfusion, wound infection, clots in the leg or lung, a need for intensive care, a bowel resection becoming necessary, a stoma, a leak where bowel is joined, injury to the bladder or ureter, fluid around the lung after diaphragm surgery, a pancreatic leak after removal of the spleen or the tail of the pancreas, a slow return of bowel function, lymph collection or leg swelling after node removal, a return to theatre, and a risk to life that is higher when extensive upper-abdominal surgery is combined with HIPEC. HIPEC adds a risk of kidney injury and low blood counts.
Four things are certainties, not risks: if both ovaries are removed, menopause is immediate and permanent; fertility ends unless a fertility-sparing operation was specifically planned; chemotherapy follows surgery; and follow-up is lifelong. Dr Swati Shah discusses each of them with you personally before the operation.
★★★★★
“My relative had advanced ovarian cancer involving the omentum and peritoneal deposits. We consulted Indian Ovarian Cancer Institute (IOCI) because of its expertise in complex ovarian cancer surgery. The doctors explained the importance of achieving complete tumour removal, and Cytoreductive Surgery (CRS) was performed successfully. We are thankful for the excellent treatment and compassionate care provided throughout the journey.”
Sharukh Bhadula, August 2026
★★★★★
“We are extremely grateful to Dr. Swati Shah for performing CRS HIPEC surgery. From the first consultation, she explained everything clearly and gave us confidence throughout the treatment journey. Her expertise, dedication, and compassionate approach made us feel comfortable and supported at every step. The surgery and post-operative care were handled very professionally, and we are very thankful for the care and guidance provided. Dr. Swati Shah is an excellent cancer surgeon, and we highly recommend her to anyone looking for expert care and treatment.”
Vaibhav Parmar, September 2026
★★★★★
“HIPEC technology very well explained,and accordingly treated my spouse,kudos, her recovery went well till now”
Deepak Goswami, August 2026
A patient of Dr Swati Shah’s describes her cytoreductive surgery for ovarian cancer (in Hindi).
What moves the estimate is the extent of the cytoreduction, whether HIPEC is added, whether a bowel resection or stoma is needed, and the days spent in intensive care and in hospital. Cashless pre-authorisation is arranged through the Apollo Hospital, Bhat, insurance desk where your policy allows it.
Plan also for the chemotherapy before or after surgery, the gene test sent at diagnosis, and maintenance medicine, which can be the largest single cost and is discussed at the first counselling rather than at the prescription.
It means no visible cancer was left anywhere in the abdomen at the end of the operation. CC-0 is the completeness-of-cytoreduction score used in peritoneal surgery; R0 says the same thing. It is the single result of the operation that most influences what happens afterwards.
No. When the CT or a diagnostic laparoscopy shows that not every deposit could be removed today, or when you are too unwell or undernourished for a long operation, three or four cycles of chemotherapy are given first. The aim is to make complete removal possible at the interval operation, which then follows. The total course of chemotherapy is still six cycles.
No. The evidence supports HIPEC at the interval operation after chemotherapy, in advanced disease, when every visible deposit has been removed. HIPEC at a first, primary operation is still investigational, and it is never added when cytoreduction is incomplete.
The operation is not continued as a partial debulking. Tissue is taken, the abdomen is closed, and chemotherapy is given first, with a planned operation later. You are told about this possibility at the consent discussion, before surgery.
Sometimes. If removing a segment of bowel is what makes the operation complete, the bowel is removed, and occasionally a temporary or permanent stoma is needed. Consent for bowel resection and stoma is always taken before the operation, and the stoma nurse marks the site in advance.
Only if they are enlarged. In advanced disease, when the nodes look normal and every visible deposit has been removed, routine removal of all the pelvic and para-aortic nodes adds complications without helping survival. In apparent early-stage disease, the nodes are removed as part of staging.
Consultation at the IOCI clinic, Gota, Ahmedabad. Surgery at Apollo Hospital, Bhat, Gandhinagar.
Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
Department
Shah’s Gastro, Cancer & Robotic Surgery Centre
SF-203, 2nd Floor
Olive Greens, Gota
S G Highway, Ahmedabad
Gujarat, India 382481
Google map link:
https://maps.app.goo.gl/2wawX5nnDgjkKoeZA?g_st=iw
Apollo Hospital I.L
Plot No. 1 A,
Apollo Hospital International Limited,
GIDC Bhat, Industrial Estate,
Gandhinagar, Gujarat 382428
Google map link:
https://maps.app.goo.gl/jRYUHgH6rFdGsk5g8